Alpha Teknova (TKNO) Cash & Current Investments (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Cash & Current Investments came in at $17.8 million in Q1 2026, down 32.31% year-on-year from $26.3 million in Q1 2025, and down 16.66% on a QoQ basis from $21.3 million in Q4 2025.
Alpha Teknova (TKNO) Cash & Current Investments (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Cash & Current Investments data on file, last reported at $17.8 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 32.31% year-over-year to $17.8 million in Q1 2026; TTM through Mar 2026 was $17.8 million, a 32.31% decrease from a year earlier, with the FY2025 full-year figure at $21.3 million, down 29.8% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $17.8 million, down from $21.3 million in the prior quarter.
- Over the last five years, Cash & Current Investments for TKNO reached as high as $76.5 million in Q1 2022 and fell as low as $17.8 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $33.0 million across 5 years, with a median of $28.5 million in 2023.
- Across the five-year window, Cash & Current Investments jumped 428.52% in 2022 and tumbled 63.37% in 2023, its largest moves.
- Year by year, Cash & Current Investments stood at $42.2 million in 2022, then sank by 32.56% to $28.5 million in 2023, then advanced by 6.71% to $30.4 million in 2024, then retreated by 29.8% to $21.3 million in 2025, then declined by 16.66% to $17.8 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $17.8 million in Q1 2026, $21.3 million in Q4 2025, and $22.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 17.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.78 Mn |
| Dec 31, 2025 | 21.34 Mn |
| Sep 30, 2025 | 22.12 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | 26.27 Mn |
| Dec 31, 2024 | 30.40 Mn |
| Sep 30, 2024 | 31.69 Mn |
| Jun 30, 2024 | 18.60 Mn |
| Mar 31, 2024 | 21.60 Mn |
| Dec 31, 2023 | 28.48 Mn |
| Sep 30, 2023 | 32.10 Mn |
| Jun 30, 2023 | 23.71 Mn |
| Mar 31, 2023 | 30.20 Mn |
| Dec 31, 2022 | 42.24 Mn |
| Sep 30, 2022 | 49.86 Mn |
| Jun 30, 2022 | 64.73 Mn |
| Mar 31, 2022 | 76.46 Mn |
| Dec 31, 2021 | 87.52 Mn |
| Sep 30, 2021 | 98.01 Mn |
| Jun 30, 2021 | 108.02 Mn |